Erythromycin, inhibitor CYP3A4, nemění farmakokinetiku risperidonu ani účinné antipsychotické frakce.
Erythromycin, a CYP 3A4 inhibitor, does not change the pharmacokinetics of risperidone and the active antipsychotic fraction.